| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $179.97M | $176.52M | $204.82M | $136.15M | $139.90M |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | $5.30M | $4.84M | $4.45M | $1.28M |
| Net Income | $119.27M | $62.87M | $195.87M | $55.00M | $192.43M |
| EPS (basic) | 1.0300 | 0.5500 | 1.8100 | 0.5400 | 1.8900 |
| EPS (diluted) | 1.0300 | 0.5500 | 1.8100 | 0.5400 | 1.8900 |
| Shares (diluted) | $115.58M | $114.67M | $108.31M | $102.26M | $101.69M |